Literature DB >> 7517931

Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein. Influence of HLA-DR4 polymorphism on T-cell clonal recognition.

D Ou1, L A Mitchell, M Ho, D Dćarie, A J Tingle, G T Nepom, M Lacroix, M Zrein.   

Abstract

A CTL antigenic site located between residues 273 and 291 of the E1 envelope protein of RV was identified by 51Cr-release assays employing SPs. Two E1-specific CTL clones were examined for immune recognition of RV wild-type and attenuated vaccine strains and recombinant E1 protein. The exact sequence (273-284) recognized by both clones was delineated by using truncated and overlapping SPs covering these residues. The defined T-cell site overlapped almost completely with a virus neutralizing antibody-binding site previously identified with mouse monoclonal and human antibodies. A series of single aa-substituted SP analogues of E1(273-284) was used to define residues critical for T-cell recognition. Using EBV-BL displaying different HLA-DR haplotypes and -DR4 subtypes as targets to determine MHC class II restriction elements, immune recognition by both T-cell clones was shown to be associated with HLA-DR4. Three HLA-DR4 subtypes (DR4Dw13A, DR4Dw13B, and DR4KT2) sharing a common residue, glutamic acid at position 74 in their beta 1 chains, were able to present SP E1(273-284) to the T-cell clones.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517931      PMCID: PMC7135096          DOI: 10.1016/0198-8859(94)90258-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  41 in total

1.  Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutinin.

Authors:  C E Hioe; N Dybdahl-Sissoko; M Philpott; V S Hinshaw
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  Nucleotide sequence of the 24S subgenomic messenger RNA of a vaccine strain (HPV77) of rubella virus: comparison with a wild-type strain (M33).

Authors:  D X Zheng; L Dickens; T Y Liu; H L Nakhasi
Journal:  Gene       Date:  1989-10-30       Impact factor: 3.688

3.  Mutational analysis of the HLA-DQ3.2 insulin-dependent diabetes mellitus susceptibility gene.

Authors:  W W Kwok; C Lotshaw; E C Milner; N Knitter-Jack; G T Nepom
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.

Authors:  L A Mitchell; T Zhang; M Ho; D Décarie; A J Tingle; M Zrein; M Lacroix
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

5.  Human T- and B-cell epitopes of E1 glycoprotein of rubella virus.

Authors:  H Chaye; D Ou; P Chong; S Gillam
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

6.  Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides.

Authors:  D Ou; P Chong; B Tripet; S Gillam
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

7.  Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.

Authors:  B M Carreno; R V Turner; W E Biddison; J E Coligan
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

8.  Polymorphism in a T-cell receptor variable gene is associated with susceptibility to a juvenile rheumatoid arthritis subset.

Authors:  W P Maksymowych; C A Gabriel; L Luyrink; H Melin-Aldana; M Elma; E H Giannini; D J Lovell; C Van Kerckhove; J Leiden; E Choi
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

9.  An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.

Authors:  J S Wolinsky; E Sukholutsky; W T Moore; A Lovett; M McCarthy; B Adame
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus.

Authors:  H Chaye; P Chong; B Tripet; B Brush; S Gillam
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

View more
  4 in total

Review 1.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

2.  HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine.

Authors:  Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Megan M O'Byrne; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2009-02-05       Impact factor: 3.641

Review 3.  Rubella.

Authors:  Nathaniel Lambert; Peter Strebel; Walter Orenstein; Joseph Icenogle; Gregory A Poland
Journal:  Lancet       Date:  2015-01-08       Impact factor: 79.321

4.  Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity.

Authors:  Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.